Terms and Definitions
Disclaimer
Preface
1. Understanding Telemedicine
   1.1. Definition
   1.2. Key Features
      1.2.1. Telemedicine-promoting Factors
      1.2.2. Telemedicine-hindering Factors

2. Background on Introduction of Telemedicine in Korea
   2.1. Before COVID-19
   2.2. Temporary Approval caused by COVID-19
   2.3. Telemedicine Pilot Program (Since 1 June 2023)

3. Telemedicine Market of Korea
   3.1. Telemedicine Market Size
      3.1.1. Market Size Immediately after COVID-19
      3.1.2. Post-Pilot Program Market Size
   3.2. Major Telemedicine Platforms
      3.2.1. GoodDoc
      3.2.2. My Own Doctor
      3.2.3. Doctor Now
      3.2.4. Doctor Call
      3.2.5. SolDoc
      3.2.6. MDtalk
      3.2.7. Hola Care
      3.2.8. oneDOC

4. Business Issues and Market Forecasts
   4.1. Prescription Drugs Not Allowed Under Telemedicine
   4.2. Feasibility of Medication Delivery
   4.3. Finding New Business Models: Integration with Remote Monitoring

Table 1 Remote Healthcare-Associated Acts
Table 2 Eligibility for Remote Healthcare Services
Table 3 Implementation Process of Telemedicine
Table 4 Temporary Approval for Phone Consulting, Prescription and Proxy Prescription (MOHW Notification No. 2020-177)
Table 5 Enforcement Decree of the Infectious Diseases Control and Prevention Act
Table 6 Temporary Approval for Telemedicine (MOHW Notification No. 2020-889)
Table 7 Article 44 of Framework Act on Health and Medical Services
Table 8 Article 33 of Medical Service Act
Table 9 Implementation Process of Telemedicine Pilot Program
Table 10 Target Patients of Telemedicine Pilot Program
Table 11 Telemedicine Pilot Program Management RBRVS for Medical Institutions
Table 12 Telemedicine Pilot Program Management RBRVS for Pharmacies
Table 13 COVID19-Related Telemedicine Market Size Including At-home Care
Table 14 Medical Institutions Participating Telehealth
Table 15 Temporary Telemedicine by Age Group
Table 16 Temporary Telemedicine by Condition
Table 17 Telemedicine Pilot Program Fees and Medical Procedures Criteria
Table 18 Telemedicine Pilot Program Administrative Fee Claims (from Jun. to Nov. 2023)
Table 19 Pilot Program Administrative Fee Claims by End-user Type (from Jun. to Nov. 2023)
Table 20 Pilot Program Administrative Fee Claims by Age Group (from Jun. to Nov. 2023)
Table 21 Pilot Program Administrative Fee Claims by Region (from Jun. to Nov. 2023)
Table 22 Implementation after Adding Supplementary Measures
Table 23 Frequently Diagnosed Conditions in Telemedicine
Table 24 Holiday and Nighttime Implementation after Adding Supplementary Measures
Table 25 Major Telemedicine Platform Services
Table 26 Service Model of Doctor Now
Table 27 Service Model of My Own Doctor
Table 28 Service Model of Doctor Now
Table 29 Service Model of Doctor Call
Table 30 Service Model of SolDoc
Table 31 Service Model of Mdtalk
Table 32 Service Model of Hola Care
Table 33 Service Model of oneDOC
Table 34 Medications of Concern for Misuse or Abuse
Table 35 Major Pilot Programs of Chronic Conditions
Table 36 Reimbursement Criteria for Continuous Glucose Monitoring and RBRVS
Table 37 Remote Monitoring Associated Platforms

Fig 1 Telehealth Spectrum
Fig 2 Telehealth and Opinions of Interested Parties
Fig 3 Number of COVID-19 Patients (as of 07 August 2023)
Fig 4 Operation of Telehealth Pilot Program
Fig 5 Operation of Telehealth Pilot Program
Fig 6 Service Rate of Medical Institutions participating in Telehealth
Fig 7 Number of Patients for Telemedicine Pilot Program from Jun. to Nov. 2023
Fig 8 Screen Capture of GoodDoc
Fig 9 Screen Capture of My Own Doctor
Fig 10 Screen Capture of Doctor Now
Fig 11 Screen Capture of Doctor Call
Fig 12 Screen Capture of Soldoc
Fig 13 Screen Capture of MDtalk
Fig 14 Screen Capture of Hola Care
Fig 15 Screen Capture of oneDoc
Fig 16 Support Rate for Pharmaceuticals Delivery Initiation
Fig 17 Delivery Method Favored by Patients
Fig 18 Overview of Primary Care Chronic Disease Management Pilot Program

GoodDoc
My Own Doctor
Doctor Now
Doctor Call
SolDoc
MDtalk
Hola Care
oneDOC